Galapagos NV (GLPG) Q1 2026 Earnings Call Transcript
Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update
Galapagos' Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders' Meetings 2026
Galapagos (NASDAQ:GLPG) Stock Crosses Below 200 Day Moving Average – Time to Sell?
Galapagos en Gilead gaan definitieve overeenkomst aan over samenwerking om een first-in-class T-cel-engagerprogramma voor auto-immuunziekten verder te ontwikkelen
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
Galapagos Announces Nomination of Gino Santini to its Board of Directors
Galapagos kondigt de voordracht aan van Gino Santini tot lid van de Raad van Bestuur
Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders' Meetings
Galapagos publiceert 2025 jaarverslag en kondigt de Gewone (jaarlijkse) en Buitengewone Algemene Vergaderingen aan
Stock Market Today (LIVE): Market Rally Fizzles as Oil Rebounds; Smithfield Foods Hams It Up
Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
Galapagos Receives Transparency Notification from Bank of America
Galapagos Receives Transparency Notifications from Bank of America
Galapagos Creates New Subscription Right Plan
Galapagos Appoints Tania Philipp as Chief Human Resources Officer
Galapagos Receives Transparency Notifications from Bank of America
Galapagos NV (GLPG) Q4 2025 Earnings Call Transcript
Galapagos Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Galapagos Receives Transparency Notification from Bank of America
Stock Market Today: Dow Jones Futures Drop After Scaling Record Highs— CoreWeave, Vistra, Microchip Technology In Focus
AngioDynamics, Microchip Technology And 3 Stocks To Watch Heading Into Tuesday
Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities
Galapagos: Pivoting From Clinical Risk To Strategic Capital Allocation
Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025
Galapagos Receives Transparency Notifications from Bank of America
Galapagos NV (GLPG) Q3 2025 Earnings Call Transcript
Galapagos to Present New Data from Cell Therapy Program at ASH 2025
Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company's Ongoing Transformation
Galapagos Announces Appointment of Fred Blakeslee as General Counsel
Biotechnology firm Galapagos receives offers for cell-therapy business
Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business
Galapagos Creates New Subscription Right Plan
Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Transformation
Galapagos Welcomes Seasoned Pharmaceutical Executives Dawn Svoronos and Jane Griffiths to Its Board of Directors
Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business Update
Galapagos Appoints Aaron Cox as Chief Financial Officer
Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101
Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL
Galapagos Creates New Subscription Right Plan
Galapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes
Galapagos: Targeting High Unmet Medical Need Of MCL Focus With GLPG5101
Galapagos NV (GLPG) Q1 2025 Earnings Call Transcript
Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts
Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025
Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders' Meeting
Galapagos to Present at Upcoming Investor Conferences